Action plan
What this genome is asking you to do.
Ranked by whether a result can change a decision this year. Common SNPs are not diagnoses. The items below are the ones with a guideline, a lab, or a clearly better habit.
This week
No lab required.
- 01
Put SLCO1B1 on the medication list
If a clinician ever starts a statin, this genome is a SLCO1B1*5 heterozygote. Simvastatin at high dose is the one to avoid. Atorvastatin, rosuvastatin, or pravastatin are the usual work-arounds. This is a CPIC-backed interaction, not a wellness guess.
SLCO1B1 rs4149056 C/T
- 02
Treat the lungs as non-renewable
One MUC5B promoter T allele raises idiopathic pulmonary fibrosis risk. The disease is still uncommon. The useful moves are boring and high-leverage: do not smoke, do not vape, avoid concentrated farm or compost dust, treat chronic reflux, and do not ignore a dry cough that lasts weeks.
MUC5B rs35705950 G/T
- 03
Eat choline on purpose
PEMT 175M/M means the liver makes phosphatidylcholine poorly. Two eggs most days covers a large share of the AI. Liver, meat, soy lecithin, or a choline bitartrate / CDP-choline supplement are backups if the diet is plant-forward.
PEMT rs7946 T/T
With a clinician
Small, high-yield blood work.
- 01
Get a small, high-yield lab set once
Ask a clinician for: fasting lipids + Lp(a) once, HbA1c or fasting glucose, ferritin + transferrin saturation, 25-OH vitamin D, and (optional) homocysteine with B12 and folate. None of these genotypes diagnose a disease. They tell you which numbers are worth knowing.
TCF7L2, FTO, 9p21, H63D, methylation stack
How to live it
Training, food, lungs, UV.
- 01
Train like a power genotype that must stay insulin-sensitive
ACTN3 RR responds well to heavy resistance and sprints. TCF7L2 and FTO make muscle and fiber unusually valuable for glucose control. A practical split: 3 lifting sessions + 1–2 short intervals + daily walking. That pattern matches this genome better than long slow cardio alone.
ACTN3 RR + TCF7L2 CT + FTO het
- 02
Do the unsexy coronary work
9p21 is lipid-independent. Blood pressure, not smoking, sleep, and cardiorespiratory fitness move this risk more than any supplement. Know the numbers: BP, ApoB or LDL, and that once-only Lp(a).
9p21 heterozygous
- 03
Coffee is genetically in-bounds
CYP1A2 *1F/*1F clears caffeine quickly. The slow-metabolizer coffee–MI story does not apply. Stop caffeine 8 hours before bed anyway if sleep is the goal. Lactase persistence means dairy in the coffee is fine.
CYP1A2 AA + LCT persistent
- 04
Get EPA/DHA from fish or algae
Intermediate FADS conversion plus a PEMT-limited phospholipid pathway is a quiet argument for actual long-chain omega-3s rather than flax-only.
FADS het + PEMT TT
- 05
Light-European skin, blue-eye UV budget
SLC24A5, SLC45A2, and HERC2 G/G describe a low-melanin iris and skin. Use sunscreen on long exposure. The vitamin D SNPs are favorable, so deficiency is more about indoor life than genes.
Pigmentation cluster
When you are ready
PGx card, counseling, deeper DNA.
- 01
Carry a one-line pharmacogenetic card
CYP2C19 normal. CYP2C9 normal. VKORC1 higher-dose haplotype. SLCO1B1 intermediate (avoid high-dose simvastatin). TPMT/DPYD common alleles normal. HLA-B*5701 tag negative. CYP2D6 possibly *3 carrier — confirm before tamoxifen or codeine if those drugs appear.
CPIC-relevant star alleles on the chip
- 02
This chip is not a cancer panel
Common BRCA, Lynch, and familial-hypercholesterolemia variants are mostly absent from 23andMe v5, and indel encodings are easy to misread. If a parent or sibling had early breast, ovarian, colorectal, or very high LDL, see a genetic counselor. Do not treat a quiet microarray as a negative clinical test.
Assay limits, not a genotype
- 03
Optional: deepen the haplogroups
Y is R1a-L260 (West Slavic). mtDNA is J1c. A Big Y or full mitochondrial sequence will split those into modern subclades and match living testers. Autosomal AIMs already say Northwest/Central European — an imputation-based ancestry tool (e.g. a research PCA) would add percentages, not a new story.
R1a-L260 + J1c + European AIMs